Conducting clinical research studies with
SKILL, KNOWLEDGE and SAFETY.
Call to participate
860.443.4567

Archive for the ‘ News Feed ’ Category

Alzheimer’s Agitation

Monday, January 22nd, 2018

Are you a stressed out caregiver? Has mom or dad become too much to handle?  Are you a spouse living with someone diagnosed with Alzheimer’s and every day is a struggle?

Agitation in Alzheimer’s disease can be unpredictable and frustrating. Symptoms can include cursing or verbal combativeness, shouting, hitting or kicking, pushing or grabbing, pacing and aimless wandering, general restlessness and more. Does this sound like your loved one?

Neurologist Dr. Laurence Radin and the CCRstudies team  are conducting the TRIAD Research Study.  Individuals with agitation due to Alzheimer’s disease along with their caregivers may be eligible to participate.  The study is evaluating and investigational medication that may help with the symptoms of Alzheimer’s agitation.  Agitation can be defined as the presence of one of more of these behavoirs:  excessive motor activity, verbal aggression, or physical aggression.

Males and females 50 to 90 years of age who have a diagnosis of probable Alzheimer’s disease may be eligible to participate.  The study has approximately 8 clinic visits over the course of 16 weeks. Reimbursement is available for time and travel.

If you know someone living at home, in an assisted living facility or in a nursing home who is living with Alzheimer’s agitation and you would like to learn more about the TRIAD Research Study, call (860) 443-4567 or email marylou@ccrstudies.com.

Has the Arctic Chill Cooled Your Hot Flashes?

Wednesday, January 3rd, 2018

Let’s face it. We’re New Englanders.  Here at Coastal Connecticut Research, we have the good fortune of being located just a block away from the Thames River in New London and a few blocks away from Long Island Sound.  We are surrounded by quaint and charming New England homes and not too far from vibrant downtown New London.  But, with New England charm comes New England weather!

The recent cold snap, known as a polar vortex, has a lot of people feeling blah.  Believe it or not, a few women who suffer with moderate to severe hot flashes have told us they actually feel a little less overheated in periods of extreme cold. We do know, however, that Mark Twain wisely noted, “if you don’t like the weather in New England, wait five minutes.”  This too shall pass!

If you are a woman who has been living with bothersome hot flashes, don’t wait for another polar vortex to find relief! Coastal Connecticut Research is currently conducting a clinical research study testing an non-hormonal medication for the treatment of hot flashes and night sweats in postmenopausal women.  We encourage you to contact us to find out more.  There’s no need to run out in the freezing weather in your shorts and t-shirt to cool off!  Learn about an investigational medication being evaluated on women living with hot flashes.  (860) 443-4567.  Gynecologist Dr. Robert Spitz is the local study doctor and all visits take place in New London.  We look forward to hearing from you soon!

November is Alzheimer’s Awareness Month

Thursday, November 2nd, 2017

 

CCRstudies is a member of the Alzheimer’s Foundation of America.

November is national Alzheimer’s Awareness Month.

Here at Coastal Connecticut Research, we’ve been heavily involved in the fight against Alzheimer’s.  We have conducted a variety of Alzheimer’s clinical research studies with primary investigator Dr. Laurence Radin, who specializes in neurology.  We have also provided community members with no cost memory screenings

as a public service through the Alzheimer’s Foundation of America’s early detection program.  To date, over 100 no cost screenings have been offered to the public through our Mobile Memory Clinics.

Over 5 million Americans are living with Alzheimer’s disease, a progressive, degenerative condition.  Research will continue to help discover and  develop improved treatments for individuals living with memory loss.

If you or someone you know is living with memory loss, has a family history of memory loss, or would like to learn more about research involving memory loss, call to speak to a member of the CCRstudies team at (860) 443-4567 or email marylou@ccrstudies.com. 

 

No Cost Memory Screenings

Thursday, June 8th, 2017

Coastal Connecticut Research in New London is offering no cost, confidential memory screenings as a service to the community for memory loss or suspected early signs of Alzheimer’s.

If you are concerned about memory loss, have a family history of memory loss, or live with someone experiencing suspected memory loss call Coastal Connecticut Research at (860) 443-4567 to book a screening appointment.  Evaluations take around 30 minutes and results can be forwarded to health care providers with consent.

Since the inception of the Alzheimer’s national memory screening program over 2.5 million people have been screened worldwide.  Locally, Coastal Connecticut Research has conducted over 100 free memory screenings as part of this Alzheimer’s initiative. Memory screenings are a significant first step towards identifying memory problems.   The screenings are conducted by medical staff trained as Qualified Dementia Care Specialists, the highest level of certification awarded by the Alzheimer’s Foundation of America.

Coastal Connecticut Research is located at 342 Montauk Avenue in New London.  Visit www.CCRstudies.com to learn more about the research site.

Migraine Headaches

Thursday, May 25th, 2017

For years, Susan had been living with incapacitating headaches that sometimes caused her to miss work or family events.  The headaches began in her late teens and have lasted until now, her mid-30’s.  Sometimes the headaches would start on a Monday and stretch all the way until Wednesday.  Quite frequently with these headaches Susan would experience nausea, as well as sensitivity to lights and sounds.  When these headaches came on, Susan would turn off all the lights, avoid people and hunker down.  What Susan did not realize is her headaches were in fact migraines!

Not everyone who lives with migraine headaches realize they are in fact getting a migraine.  3 million Americans are currently suffering with this condition.  Vision can become blurred, people can experience fatigue, stomach upset, and intense, throbbing pain.

Research is underway in New London testing an investigational medication for the prevention of migraine headaches. Dr. Laurence Radin, Dr. Edward McDermott, and Andrea Stewart APRN are members of a  Migraine Prevention Study  research team in New London. Individuals living with migraine headaches who may wish to learn more about this 9-month research study are welcome to call to speak with a member of the CCRstudies team at (860) 443-4567 or email marylou@ccrstudies.com.

 

Understanding Alzheimer’s Research

Monday, May 8th, 2017

Recently, we had the pleasure of attending the first annual Senior Strong Summit in Mystic, Connecticut. The program focused on topics ranging from estate planning to Alzheimer’s disease care giving and research.  The event was organized by the Mystic Geriatrics Institute, an newly formed non-profit with a focus on the changing face of elder care and empowering seniors.

We feel it’s important to participate in such events to educate the public on the important role research plays in the future treatment of disease.  Ideally those who conduct research throughout the world can someday find a cure for this global epidemic of the aging population which currently affects 5 million Americans.  What we shared with those in attendance is the current research at our site takes different approaches to Alzheimer’s.  Some of studies testing investigational medications focus on improving Alzheimer’s symptoms, with a future goal of better treating the disease.   We have tested investigational medications designed to target memory, thinking, reasoning and cognition. We are also in the process of testing an investigational medication for those living with mild dementia designed to promote better sleep.  Observational studies, those studies that do not test a medication, have looked at ways to diagnose Alzheimer’s earlier and more accurately. Some observational studies focus on biomarkers such as blood,  brain wave patterns and Amyloid proteins on the brain.  Just as each and every person is different, each and every research study we conduct is different. Our studies are conducted with highest ethical standards.

As noted to those who attended the Senior Strong Summit, clinical research follows a protocol which is black and white, but Alzheimer’s disease has many shades of gray and creates some complex issues for the person suffering from the disease and those caring for the person living with the disease.   Those who consent to clinical research are participating as volunteers, and their participation can someday help others living with the same condition.

Call us at (860) 443-4567 if you would like to learn more about research or wish for us to participate in your next event.

 

Technology and the Brain

Wednesday, April 12th, 2017

We in the 21st century are living in an advanced age.  At the click of our fingers, we have access to a plethora of information thanks to the world wide web.  Virtually everyone carries a smartphone, a revolution in technology.  So much for looking things up in our “Funk and Wagnalls” encyclopedia!

The advent of technology has also had an impact on modern medicine and research.  Technology that provides “a window on the brain”* has become a part of the clinical trial process for Alzheimer’s research.

To better treat Alzheimer’s, we need to better understand the disease.  Research which looks at markers for having dementia – brain wave patterns, blood, thinking, reasoning, and remembering, can help better diagnose and ultimately monitor Alzheimer’s  in the future.  MRI’s, CT scans and PET scans are also utilized.

A research registry is currently enrolling eligible volunteers ages 50 and above who have cognitive impairment of suspected Alzheimer’s disease.  The research opportunity provides a no cost PET scan (positron emmission tomography),  This “picture of the brain” will help to identify the amyloid plaque (a buildup of sticky protein) in the brain.  These proteins are one of the hallmarks of memory disease.

Those who are interested in learning more about research opportunities for individuals with memory loss are welcome to contact Coastal Connecticut Research at (860) 443-4567.  The memory loss research team includes local neurologist Dr. Laurence Radin, Andrea Stewart APRN, Diane Palmer RN, Jeannine Elliott RN and Jessie Hatfield LPN.

 

 

 

 

 

*The Dana Alliance for Brain Initiatives

Migraine Headache Research

Thursday, January 19th, 2017

Research will be underway shortly in New London to test the safety and efficacy of a migraine prevention treatment.  Currently 3 million Americans report they suffer with migraine headaches. Migraine symptoms can range from moderate to severe and the headaches can start as early as childhood or young adulthood.

When someone is suffering from a migraine, they may experience nausea, blurred vision or auras, a sensitivity to lights, sounds, and odors, as well as a persistent throbbing pain behind the eyes or temples. A migraine can be “the mother of all headaches” in regards to the sometimes crippling pain.  This pain may be present on one of both sides of the head.  A migraine can last anywhere from 4 to 72 hours.  Researchers have taken a look at a variety of factors that might lead to a migraine including the chemical balance in the brain, hormonal fluctuations and reactions to food, environment and stress among other contributors.

Dr. Laurence Radin, New London neurologist, will serve as the Migraine Prevention study’s Primary Investigator. His team will consist of Andrea Stewart APRN and Jessie Hatfield LPN.  The study will be conducted at Coastal Connecticut Research in New London.  Those interested in learning more can call and speak to a member of the CCRstudies team at (860)443-4567 or email marylou@ccrstudies.com.

Overactive Bladder

Monday, December 19th, 2016

Susan, 67,  had lived with frequent urination for the past several years.  Rushing to the bathroom, being unable to sit through a movie, always making a trip to the restroom before ordering at a restaurant and returning to the restroom prior to dessert were par for the course for Susan.  A few times a week, Susan barely made it to the bathroom since she felt such a sudden urge to urinate.  She wore pads daily, an expense she did not like incurring but felt was necessary for those times she didn’t quite make it to the toilet and leaked.

Susan was unaware she was living with a real medication condition known as Overactive Bladder or OAB.  With a normal bladder, you control when you go to the bathroom.  With Overactive Bladder, you are controlled by the frequent and sudden urges to urinate.

In addition to not knowing she was living with Overactive Bladder (OAB), Susan was also unaware there were medications on the market to help control the symptoms of this condition.  She heard about a research study seeking women living with Overactive Bladder and it finally occurred to her this is something she might be living with.

Unfortunately, quite a few women living with OAB might dismiss their symptoms.  Some women may attribute their lack of bladder control to aging, childbirth or weakened muscles.  Some might think these symptoms are normal, or there is nothing they can do about it.

Investigational medications and FDA-approved medications continue to be tested in the clinical trial process to evaluate their safety and efficacy.  Clinical research is underway in New London on a FDA-approved medication.  Women who are 65 and older who visit the bathroom more than 8 times per day might be interested in learning more.  Robert M. Spitz, MD is the study doctor.  Call (860)443-4567 or email marylou@ccrstudies.com to learn more.

Decreased Desire Study Update

Monday, November 7th, 2016

Research volunteers truly do make a difference in this world.  It has been announced The Reconnect Studies, investigating bremelanotide as an on-demand treatment for premenopausal women diagnosed with hypoactive sexual desire disorder (HSDD) has met the pre-specified co-primary efficacy endpoints in both Phase 3 clinical trials.

Palatin is developing bremelanotide as a subcutaneous, on-demand, as needed treatment for women who have not yet experienced menopause and have been diagnosed with HSDD.

“It was reported women using bremelanotide had clinically meaningful and statistically significant improvements in their desire and associated distress which are the defining clinical issues for an HSDD diagnosis,” said Carl Spana, Ph.D., President and CEO of Palatin.  He continued, “I am especially grateful to all of the women who volunteered to be a part of these studies.”

The CCRstudies team wishes to thank those women who came forward to participate in The Reconnect Study here in New London.  Dr. Robert Spitz served as the Primary Investigator of the study conducted at Coastal Connecticut Research, and Jessie Jellison Hatfield, LPN served as Study Coordinator.  We are truly grateful for all those who continually come forward to participate in research!

If you wish to learn more about becoming a volunteer for current or future studies are welcome to contact us today at (860)443-4567.